User:Lyndellsampsont
From CVK
IXIARO is manufactured at Intercell's proprietary manufacturing facility in Scotland and is prepared technical analysis tradestation forex robot manufactured for the U.S. Intercell AG is an innovative biotechnology company that designs and develops novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical needs. Japanese Encephalitis is a mosquito-borne infection that strikes 30,000 to 50,000 individuals a year, causing 10,000 to 15,000 deaths (both probably an underestimate due to underreporting and other factors).
Aureus, which is being developed with Merck Co. � Consolidating under bombay stock exchange india the 26-day moving average and a thin Ichimoku � cloud �. Approximately 30,000 to 50,000 cases of JE are reported in Asia each year, and the actual number of cases are likely much nasdaq technical analysis software higher due to underreporting in rural excel moving average filter areas. Intercell's vaccine is a purified, inactivated product for active immunization against viral infections of Japanese Encephalitis. The total development time of this vaccine from research to approval took more than 10 years. ICLL) today announced that the U.S.
Intercell's vaccine to prevent Japanese Encephalitis is the company's first product on the market. JE is fatal in approximately 30 percent of those who show symptoms and leaves half of survivors with permanent brain damage. As there is no specific treatment for JE, health care experts recommend vaccination nasdaq trading analysis software as the only highly effective protection for the millions of travelers and military personnel who live in or mathematical graphing software travel to areas where the virus circulates. Late this week, or later this month we favour a break above botswana stock exchange the recent high at 120.04 towards the middle of the broad band which has held since October. Intercell is also in clinical trials of a vaccine enhancement patch with injected pandemic influenza vaccines (one shot plus patch). The vaccine was also approved by the Australian Therapeutic Goods Administration (TGA) indian stock market in and is expected to be approved shortly by the European Union following a positive CHMP-opinion. Euro rallies against Yen to bounce back from 120.0
� The Euro rallied on from 117.07 to 120.00 to react downwards losing all gained ground retracing to 1.16.64 during � Asian late Asian session the Euro seems to be pulling together to move up with resistance at 118.00 on focus.
Novartis AG holds marketing and distribution rights for IXIARO in the United States, Europe, Japan, South Korea and certain other markets in Asia and Latin America. These data were published in The Lancet in December 2007. Intercell's novel Japanese Encephalitis vaccine is a purified, moving average inactivated vaccine for active immunization against the Japanese Encephalitis virus. Market - will be adult travelers and military personnel who visit or are deployed to affected countries, including India, China, and other parts of Asia.
Planned for Q2 2009
VIENNA, / / -- Intercell AG (VSE. Intercell's stock exchange today Phase III trials for the vaccine found that the vaccine demonstrated excellent immunogenicity against Japanese Encephalitis and an overall clinical safety profile similar to placebo, combined with an excellent local tolerability profile. Intercell Announces stock charting software FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
- U.S. The approval of IXIARO by the FDA - part of a regulatory process that included parallel filings in Europe and Australia - puts us in a select group of biotechnology companies with both an FDA-approved product and an outstanding pipeline of promising vaccine candidates," said Intercell's Chief Executive Officer, Gerd Zettlmeissl.
As there is no specific treatment for JE, vaccination is the only highly effective protection for the millions of travelers and military personnel who live in or travel to areas where the virus circulates. Intercell will directly distribute and market IXIARO to the U.S. In gifford riga stock exchange of breaking resistance at 118.00, a bottom would have been set and further strength could fuel the Euro to 120.00.Nicole Elliot, senior technical analyst at Mizuho Corporate Bank, observes the possibility of the Euro breaking through 120.0 level. "This approval is a major achievement for Intercell, and it marks a significant milestone in this company's history.
The vaccine was developed under a Collaborative Research and Development Agreement with the indian stock market tips Walter Marchall Army Institute of Research, a biomedical research laboratory for the U.S. "With this decision, Americans - both civilians and military personnel - will have an efficacious and safe way to protect themselves from the devastating and deadly effects of Japanese Encephalitis."
JE is a deadly infectious disease found mainly in Asia. Intercell is listed on the Vienna stock exchange under the symbol "ICLL". Japanese Encephalitis is the leading cause of viral neurological disease aust stock exchange and disability in Asia and the most important viral encephalitis in Asia. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE). The disease is most com in several developing countries in Asia, including India and China.
FDA approves Intercell's first marketed product, a new vaccine against Japanese Encephalitis for travelers and military personnel
- Commercial product launch in the U.S. Such statements involve certain known and unknown risks, uncertainties and other new york stock exchange history factors which could cause the actual results, financial condition, performance or achievements of Intercell AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Prior to approval, the vaccine was tested in a series of large-scale clinical trials with around 5,000 individuals. In addition, four other products focused on infectious diseases are in pre-clinical development. � Asian markets tumble on on concerns about the global financial system
� Asian stock markets have opened the week with declines on widespread winnipeg stock exchange concerns of a distant economic recovery on the back of new government bailouts to AIG and Citigroup. Stock markets were driven lower mainly by banks Mitsubishi UFJ and Mizuho Financial Group have posted losses above 4% on in Tokyo, on investors � fears about the health of the global banking ro and Pound slightly down, Yen steadyEuro and Pound have opened the week with slight declines against the Dollar while the Yen remains at the same levels as on Friday.The Euro has dropped from about 1.2640 at Asian opening times declining to a session low of 1.2545 although it has bounced back and at the moment of writing, ahead of European session opening, the European united currency advances higher towards 1.2600.The Pound traded about 1.4300 in Asian session opening times and fell afterwards to a session low of 1.41800 to recover ahead of European session to advance towards 1.4280/90.The USD JPY has moved sideways during � Asian session from a minimum of 97.00 to a maximum level right below 98.00. Up to 50 percent of survivors have persistent neurological sequelae. The Company's technology platforms include an antigen-discovery system, two proprietary adjuvants and a novel patch-based delivery system.
The total development time of this vaccine took more than 10 years. The vaccine was developed under a Collaborative Research and Development Agreement with the Walter Michale Army Institute of Research in the U.S. Tokyo Nikkei 225 index has lost 4% on while the South Korean Kospi Index lost 3.6% and Hong Kong � Hang Seng Index went 3.8% down. This communication expressly or implicitly contains certain forward-looking statements concerning Intercell AG and its business.
